FdaApplication

ANDA 204661

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA
application_typeANDA
approval_date2017-06-13

Products (2)

ProductActive ingredientStrengthDosage form
OMEPRAZOLEOMEPRAZOLE40MGCAPSULE, DELAYED REL PELLETS;ORAL
OMEPRAZOLEOMEPRAZOLE20MGCAPSULE, DELAYED REL PELLETS;ORAL

2 products